WeedWeek edition
/ March 24, 2022
One of the biggest deal yet…
WeedWeek edition
March 21, 2022
How to nail 4/20 for your brand
WeedWeek edition
March 18, 2022
Why weed brands love DTC sales
WeedWeek edition
March 14, 2022
Glass House bets big on scale
WeedWeek edition
March 10, 2022
SCOOP: Top LA pot regulator steps down
WeedWeek edition
March 07, 2022
Why MSO earnings are soft
WeedWeek edition
March 04, 2022
Interstate trade talk revives in Calif.
WeedWeek edition
February 28, 2022
MedMen exits Florida in $83M deal
WeedWeek edition
February 25, 2022
MSOs oppose Illinois equity bill
WeedWeek edition
February 17, 2022
Ascend calls MedMen cannabiz “pariah”
WeedWeek edition
February 14, 2022
New York bill could accelerate REC access
WeedWeek edition
February 10, 2022
N.Y. cracks down on gray market
WeedWeek edition
February 08, 2022
NY Gov resists MedMen subpoena
WeedWeek edition
February 03, 2022
How to save cannabis equity
WeedWeek edition
January 31, 2022
Three cannabiz court cases to watch
WeedWeek edition
January 28, 2022
Amazon endorses GOP legalization bill
WeedWeek edition
January 25, 2022
MedMen countersues Ascend over broken N.Y. deal
WeedWeek edition
January 20, 2022
MedMen founder Bierman tells his story
WeedWeek edition
January 17, 2022
Ascend sues MedMen over broken N.Y. deal
WeedWeek edition
January 13, 2022
California biz rallies in Sacramento
WeedWeek edition
January 11, 2022
Budweiser-maker and Tilray break up
WeedWeek edition
January 07, 2022
MedMen / Ascend dispute escalates
WeedWeek edition
January 04, 2022
MedMen terminates N.Y. deal with Ascend
WeedWeek edition
December 27, 2021
WeedWeek’s cannabiz predictions for 2022
WeedWeek edition
December 21, 2021
Ten biggest weed stories of 2021
